There is a notice on the website of China Cancer Foundation that it will take 25 working days to reply after the materials are submitted, so we can only wait and see.

The role of Herceptin:

Also known as composer Tozumab, it is a monoclonal antibody against Her 2. It can prevent human epidermal growth factor from attaching to Her2, thus preventing the growth of cancer cells. Herceptin can also stimulate the body's own immune cells to destroy cancer cells.

It is suitable for the treatment of metastatic breast cancer with overexpression of HER2: as a single drug, it has accepted 1 or above chemotherapy regimen; Combined with taxanes in the treatment of metastatic breast cancer, no chemotherapy is needed.